Moreover, PLAU, as a prognostic marker, was found to promote CAFs conversion and the proliferation and migration of esophageal squamous cell carcinoma via the uPAR/Akt/NF-κB/IL8 pathway39. The gene discussed is PLAU; the disease is esophageal squamous cell carcinoma.